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Abstract
Lmna2/2 mice display multiple tissue defects and die by 6–8 weeks of age reportedly from dilated cardiomyopathy with
associated conduction defects. We sought to determine whether restoration of lamin A in cardiomyocytes improves cardiac
function and extends the survival of Lmna2/2 mice. We observed increased total desmin protein levels and disorganization
of the cytoplasmic desmin network in ,20% of Lmna2/2 ventricular myocytes, rescued in a cell-autonomous manner in
Lmna2/2 mice expressing a cardiac-specific lamin A transgene (Lmna2/2; Tg). Lmna2/2; Tg mice displayed significantly
increased contractility and preservation of myocardial performance compared to Lmna2/2 mice. Lmna2/2; Tg mice
attenuated ERK1/2 phosphorylation relative to Lmna2/2 mice, potentially underlying the improved localization of
connexin43 to the intercalated disc. Electrocardiographic recordings from Lmna2/2 mice revealed arrhythmic events and
increased frequency of PR interval prolongation, which is partially rescued in Lmna2/2; Tg mice. These findings support our
observation that Lmna2/2; Tg mice have a 12% median extension in lifespan compared to Lmna2/2 mice. While significant,
Lmna2/2; Tg mice only have modest improvement in cardiac function and survival likely stemming from the observation
that only 40% of Lmna2/2; Tg cardiomyocytes have detectable lamin A expression. Cardiomyocyte-specific restoration of
lamin A in Lmna2/2mice improves heart-specific pathology and extends lifespan, demonstrating that the cardiac pathology
of Lmna2/2 mice limits survival. The expression of lamin A is sufficient to rescue certain cellular defects associated with loss
of A-type lamins in cardiomyocytes in a cell-autonomous fashion.
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Introduction
Nuclear lamins are type V intermediate filament proteins that
are implicated in a variety of cellular processes, including DNA
replication, gene transcription and chromatin organization
[1,2,3,4]. Mutations within the A-type lamin gene, LMNA, are
associated with over 13 different tissue-specific diseases, collec-
tively termed laminopathies. These include autosomal Emery-
Dreifuss muscular dystrophy (EDMD2/3), limb-girdle muscular
dystrophy type 1B (LGMD1B), and dilated cardiomyopathy with
conduction defects 1A (CMD1A). Adipose, bone, and neural
tissues can also be affected in laminopathies, which may resemble
aspects of accelerated or premature aging (for review see Worman,
et al. 2010) [5,6].
Mice lacking the Lmna gene appear normal at birth but
progressively display multiple tissue defects, including muscular
dystrophy and dilated cardiomyopathy, with a noticeable reduc-
tion in growth rate beginning as early as 2 weeks of age followed
by premature death at 6–8 weeks [7]. Further analysis of hearts
from Lmna2/2 mice has revealed a rapid development of left
ventricular dilatation coupled with decreased systolic function
beginning after 2 weeks of age [8]. Dosage of A-type lamins can
also influence cardiac function as Lmna+/2 mice display cardiac
conduction defects with a late onset of dilated cardiomyopathy [9].
However, expression of either major isoform alone, lamin A only
[10] or lamin C only [11], is sufficient to prevent phenotypes
observed in Lmna2/2 mice, indicating that either isoform can
largely compensate for the other. Interestingly, only homozy-
gous—but not heterozygous—knock-in mouse models for either
muscular dystrophy-associated or cardiac-specific LMNA muta-
tions [12,13] display dilated cardiomyopathy with conduction
defects and premature death. In contrast, humans heterozygous
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for the corresponding missense mutations [14,15] develop cardiac
and skeletal muscle pathology, indicating that there are subtle
differences in disease manifestation between rodents and humans.
In this study, we tested whether cardiomyocyte-specific expres-
sion of lamin A [16] can improve cardiac function and increase
lifespan of Lmna2/2 mice. We show better preservation of
myocardial performance and reduced occurrence of conduction
abnormalities for Lmna2/2 mice expressing the cardiac transgene.
These observations are consistent with a partial restoration of
localization and protein levels of desmin, connexin43 and ERK1/
2 phosphorylation. The heterogenic expression of the cardiac
lamin A transgene in Lmna2/2 hearts underlies this partial
restoration and limits lifespan extension, however, with this model
we are able to investigate cell-autonomous and non-cell autono-
mous roles which lends insight into the biology of A-type lamins in
the cardiac system.
Results
Cardiac-specific expression of FLAG-tagged human lamin
A in Lmna2/2 mice
To determine whether cardiac-specific expression of lamin A
can improve heart function in Lmna2/2 mice, we crossed
transgenic mice expressing FLAG-tagged human lamin A under
the a-myosin heavy chain promoter [16] with Lmna+/2 mice to
ultimately produce litters containing both Lmna2/2 mice and
Lmna2/2 mice expressing the cardiac-specific LMNA transgene
(Lmna2/2; Tg). FLAG-lamin A is highly expressed in Lmna2/2; Tg
cardiac tissue as measured by Western analysis using an A-type
lamin antibody (Figure 1A), and expression is specific to cardiac
tissue in both Lmna+/+; Tg and Lmna2/2; Tg mice (Figure 1B).
Indirect immunofluorescence microscopy using antibodies against
myosin heavy chain (MF-20) and FLAG (Figure 1C) indicate
that ,35% of ventricular myocytes express the FLAG-lamin A
transgene in both Lmna+/+; Tg and Lmna2/2; Tg hearts
(Figure 1D). Finally, expression of the cardiac-specific transgene
in Lmna2/2; Tg mice does not improve the growth defect of
Lmna2/2 mice as measured by their body weights compared to
Lmna+/+ mice (Figure 1E). Collectively, these results show that
the FLAG-lamin A transgene is highly – though mosaically –
expressed and specific to cardiomyocytes.
Characterization of molecular phenotypes associated
with cardiac structure and remodeling in Lmna2/2 and
Lmna2/2; Tg hearts
Western analysis was performed on lysates derived from hearts
of 5–7 week old Lmna+/+ Lmna2/2, and Lmna2/2; Tg mice to
determine whether molecular phenotypes are restored in the
presence of cardiac lamin A expression. Desmin, previously
determined to be mislocalized in Lmna2/2 cardiomyocytes [8],
exhibits an approximately 3-fold increase in total protein levels
from Lmna2/2 hearts (Figure 2A). This finding in cardiomyo-
cytes contrasts with skeletal muscle myoblasts from Lmna2/2 mice,
where desmin levels are reduced [17]. Expression of FLAG-lamin
A in the heart results in attenuation of total desmin that is only
approximately 2-fold increased compared to Lmna+/+ hearts.
Desmin is mislocalized in Lmna2/2 ventricular myocytes, resulting
in diminished staining in the majority of intercalated discs
(Figures 2B vs. 2C) as well as increased cytoplasmic desmin
staining in,21% of ventricular myocytes (P,0.001) (Figure 2E).
Less than 1% of transgene-expressing ventricular myocytes from
Lmna2/2; Tg mice display increased cytoplasmic desmin
(P,0.001) (Figures 2D and 2E), suggesting cell-autonomous
rescue of desmin localization. Due to the mosaic nature of our
transgene expression, we continued to observe increased cytoplas-
mic desmin in the transgene-non-expressing ventricular myocytes,
but also noted a 38% reduction in the fraction of these cells,
possibly due to neighboring transgene-expressing ventricular
myocytes (P,0.01; see Discussion). These findings are consistent
with the increase of desmin in hearts of Lmna2/2 mice and the
partial attenuation of desmin levels in Lmna2/2; Tg mice.
Improved cardiac contractile function in transgenic
Lmna2/2 mice
To determine whether transgenic expression of FLAG-lamin A
improves cardiac function in Lmna2/2 mice, transthoracic
echocardiograms were performed at 4–8 weeks of age. Echocar-
diographic measurements comparing Lmna+/+ and Lmna+/+; Tg
mice showed no significant difference (Figure S1 A–C). Lmna2/2
mice display impaired contractility and left ventricular dilatation
(Figure 3A). They have significantly increased (P,0.001) left
ventricular end-systolic diameters (LVESD) and left ventricular
end-diastolic diameters (LVEDD) normalized for body weight
between Lmna2/2 and Lmna+/+ littermates (Figures 3B & 3C).
Additionally, Lmna2/2 hearts are enlarged as shown by the ,55%
increase in the left ventricular mass index (LVMI) (Figure S2).
Fractional shortening decreased by 50% in Lmna2/2 mice
compared to Lmna+/+ littermates (P,0.001) (Figure 3D) and
consistent with previous observations [8]. As a second measure of
cardiac function, the myocardial performance index (MPI) was
calculated (See methods for further details; increased MPI scores
have been shown previously to reflect LV systolic and/or diastolic
dysfunction [18]). Lmna2/2 mice display 100% increase in MPI
compared to Lmna+/+ littermates (P,0.001) (Figure 3E), consis-
tent with decreased cardiac contractility in Lmna2/2 mice.
The expression of FLAG-lamin A partially restores cardiac
contractility in Lmna2/2 mice (Figures 3A, 3B, 3D). Compared
to Lmna2/2 mice, Lmna2/2; Tg mice significantly attenuate
dilation of LVESD by ,25% (P,0.01) (Figure 3B) and display
,60% improvement in fractional shortening (P,0.001) although
fractional shortening is still 20% lower in comparison to control
littermates (P,0.001) (Figure 3D). Similarly, the MPI is partially
improved by ,25% in Lmna2/2; Tg mice compared to Lmna2/2
mice (P,0.01) (Figure 3E). However, hearts of Lmna2/2; Tg
mice still exhibit cardiac enlargement, as LVEDD (Figure 3C)
and LVMI (Figure S2) are not significantly changed compared
to hearts of Lmna2/2 mice. Furthermore, mRNA expression of
atrial natriuretic factor and brain natriuretic peptide, hallmarks of
cardiac remodeling and physical stress, are not significantly
changed in hearts of Lmna2/2; Tg mice compared to those from
Lmna2/2 mice (Figure S3). Collectively, these data indicate that
the mosaic expression of FLAG-lamin A in Lmna2/2 cardiomy-
ocytes results in partial but significant restoration of cardiac
contractility compared to Lmna2/2, yet fails to ameliorate cardiac
dilation and remodeling.
Characterization of molecular phenotypes associated
with cardiac conduction in both Lmna2/2 and Lmna2/2;
Tg mice
Increased ERK signaling as reflected by levels of phosphory-
lated ERK1/2 (pERK1/2) has been observed in hearts of
LmnaH222P/H222P mice [19] and in other cell systems with
knockdown of A-type lamin or emerin expression [20]. Consis-
tently, we detect a 2.5-fold increase of pERK1/2 in Lmna2/2
hearts relative to total ERK1/2 levels (P,0.01) (Figure 4A and
4B). Although we were unable to achieve significance, Lmna2/2;
Tg (n= 11) hearts trend towards a reduced pERK1/2 level
Cardiac Rescue of Lmna2/2 Mice
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compared to hearts from Lmna2/2 mice (n= 16), suggesting that
there may be a partially decreased cellular stress response.
Increases in ERK1/2 activity have been shown to negatively
affect gap junction communication through phosphorylation of
connexin43 (Cx43) [21,22]. We find no significant change in levels
of total Cx43 as detected by the NT1 antibody. However, in
Lmna2/2 hearts we detect a significant increase in CT1 signal, an
antibody which predominantly recognizes Cx43 found in the
cytoplasm and is increased in ischemic hearts [23] (Figure 4A).
The increase in CT1 signal is not significantly attenuated in the
hearts from Lmna2/2; Tg mice. In addition to changes detectable
by immunoblot, we also observe a decreased amount of gap
junctional Cx43 in hearts from 5–7 week old Lmna2/2 mice
compared to similarly aged Lmna+/+ mice via immunofluorescence
(Figures 4C and 4D). Hearts from Lmna2/2; Tg mice appear to
have more Cx43 present at the gap junction than hearts from
Lmna2/2 mice (Figure 4E). To quantitatively assay the loss of
Cx43 in the intercalated discs of ventricular myocytes from 5–7
week old Lmna2/2 mice, we formulated a co-association index for
scoring Cx43 at intercalated discs (see methods). Intercalated discs
from Lmna+/+ ventricular myocytes display a mean Cx43 index of
0.70, which is reduced to 0.39 in Lmna2/2 ventricular myocytes
(Figure 4F). Intercalated discs from Lmna2/2; Tg ventricular
myocytes display a mean Cx43 index of 0.53. When normalized
against the mean index for Lmna+/+ ventricular myocytes for each
experiment, ventricular myocytes from Lmna2/2 mice display
45% decrease in Cx43 localization at the intercalated disc
(P,0.01) (Figure 4G). In contrast, ventricular myocytes from
Lmna2/2; Tg mice display 25% decrease in Cx43 localization at
the intercalated disc compared to Lmna+/+ ventricular myocytes
(P = 0.11), suggesting a partial restoration of Cx43 localization at
the intercalated disc.
Transgenic Lmna2/2 mice have less severe conduction
defects
We hypothesized that if Cx43 localization was partially
restored in Lmna2/2; Tg mice, there may be improvements in
cardiac conduction. To test this hypothesis, we took electrocar-
diography (ECG) recordings of 5–7 week old mice and measured
a number of parameters associated with cardiac conduction,
including PR and QRS intervals. Despite the previous study
reporting a significant increase in the average PR and QRS
intervals for Lmna2/2 mice [8], we were unable to observe a
significant increase in the average PR or QRS intervals of
similarly aged Lmna2/2 mice after analyzing 300 beats per
mouse (N= 5) using this method (Table S1). However,
intermittent prolongation of the PR interval was noted in
Lmna2/2 mice. Since there is no consensus on the normal
reference values for PR intervals, we derived the reference values
by analyzing 1,500 beats from 5 Lmna+/+ littermates, which
display a Gaussian distribution. PR intervals from single mice
were then compared against the derived reference value and
Figure 1. FLAG-lamin A is highly expressed, tissue-specific, and mosaic. (A) Western blot analysis of Lmna+/+, Lmna2/2, and Lmna2/2; Tg
heart lysates that were probed with lamin A/C antibody. (B) Western blot analysis of heart, gastrocnemius, quadriceps, thymus, spleen, kidney, liver,
and lung from Lmna+/+; Tg (upper panel) and Lmna2/2; Tg (lower panel) mice probing with lamin A/C antibody. The asterisk indicates a cross-reactive
band present in all lanes. (C) Indirect immunofluorescence micrograph of Lmna2/2; Tg heart cross-section stained for MF-20 (cardiomyocytes; green),
FLAG (transgene; red), and DAPI (nuclei, blue). Note that the mosaic expression of the transgene is limited to only cardiomyocytes. Scale bar denotes
100 mm. Inset is zoomed in view from the same image. (D) Quantitation of the percent of cardiomyocytes expressing FLAG-lamin A (N=3 each;,500
cardiomyocytes were scored for each group) (E) Body weights of Lmna+/+, Lmna2/2, and Lmna2/2; Tg mice (N= 10, 11, and 8 at 4–6 weeks
respectively and N=10, 7, and 5 at 6–8 weeks respectively).
doi:10.1371/journal.pone.0042918.g001
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values greater than 95% of our normal reference were
considered abnormally prolonged (Figure 5A). Using the cut-
off value of .30% abnormally prolonged PR intervals, 5 out of 6
Lmna2/2 mice displayed PR prolongation (Fisher’s exact test,
P = 0.0476), suggesting the presence of first degree atrioventric-
ular block (Figure 5B). In contrast, 2 out of 5 Lmna2/2; Tg
mice exhibited PR prolongation (Fisher’s exact test, P = 0.2222),
suggesting partial improvement in atrioventricular conduction
due to cardiac-specific FLAG-lamin A expression. One Lmna+/+;
Tg mouse exhibited .30% PR interval prolongation and a
second mouse displayed a dropped beat (Figure S4), which
might be a manifestation of sinus pause, sinoatrial or atrioven-
tricular block, suggesting that increased expression of lamin A in
a subset of normal myocytes can also result in conduction
abnormalities. We also observe several arrhythmic events in
Lmna2/2 mice. Compared to a normal ECG tracing from a
representative Lmna+/+ mouse (Figure 5C), the ECG of Lmna2/
2 mice display intermittent atrial premature beat (Figure 5D)
and a multifocal atrial rhythm (Figure 5E). We were unable to
locate any similar arrhythmic occurrences in Lmna2/2; Tg mice,
potentially due to improved cardiac function.
Transgene expression of FLAG-lamin A in Lmna2/2
cardiomyocytes extends lifespan
Concurrent with our studies of cardiac function and molecular
restoration in cardiomyocytes from Lmna2/2; Tg mice, we sought
to determine whether this improvement would translate into an
increased lifespan. Kaplan-Meier curves were generated from a
cohort of 24 and 28 mice each for transgenic and non-transgenic
Lmna2/2 mice, respectively. Despite the mosaic expression of
FLAG-lamin A in Lmna2/2; Tg cardiomyocytes, we observe a
12% mean increase and a 15% maximal increase in lifespan
(P,0.011) of Lmna2/2; Tg mice compared to non-transgenic
Lmna2/2 littermates (Figure 6).
Discussion
In this study, we tested the hypothesis that cardiomyocyte-specific
expression of lamin A in Lmna2/2mice can restore cardiac function
and increase lifespan. Through the generation of Lmna2/2 mice
with cardiomyocyte-specific expression of FLAG-lamin A, we
observed significantly improved fractional shortening and myocar-
dial performance index by echocardiogram, restored localization of
Figure 2. Transgenic expression of lamin A in Lmna2/2 cardiomyocytes results in partial restoration of desmin phenotype but not
cardiac remodeling markers. (A) Western blot analysis of Lmna+/+, Lmna2/2, and Lmna2/2; Tg whole heart lysates. Desmin is increased in Lmna2/2
heart lysates compared to Lmna+/+ and is partially attenuated in Lmna2/2; Tg mice (middle blot). a-tubulin is shown as a loading control (bottom blot).
(B–D) Indirect immunofluorescence micrographs showing desmin (red), FLAG (green), and DAPI (blue) in Lmna+/+ (B), Lmna2/2 (C), and Lmna2/2; Tg (D)
heart ventricle sections. Asterisks mark intercalated discs, which co-localize with a pan-cadherin antibody (not shown) and arrows indicate ventricular
myocytes with accumulated desmin in the cytoplasm. Scale bar denotes 50 mm. (D) Note the lack of ventricular myocytes positive for both desmin
cytoplasmic accumulation and transgene expression. (E) Graph summarizing the desmin cytoplasmic accumulation phenotype observed in Lmna2/2
ventricular myocytes across different mouse backgrounds aged 5–7 weeks (N= 3 for Lmna+/+, Lmna2/2, and Lmna2/2; Tg; ** P,0.01; *** P,0.001).
doi:10.1371/journal.pone.0042918.g002
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both desmin and Cx43, and attenuated protein levels of both
pERK1/2 and desmin, resulting in partial restoration of cardiac
function compared to Lmna2/2 mice. Despite increased cardiac
contractility, cardiac remodeling in transgenic Lmna2/2 mice was
still evident with no amelioration of chamber dilation. We observed
less Cx43 localized to the intercalated disk in ventricular myocytes
of Lmna2/2 mice which was partially restored in ventricular
myocytes of Lmna2/2; Tg mice. This modest improvement in Cx43
localization was also consistent with our finding that the stochastic
PR interval prolongation observed in Lmna2/2 mice is less frequent
in Lmna2/2; Tg mice. The improvements to cardiac function due to
the expression of lamin A resulted in a significant—though
modest—extension in lifespan compared to Lmna2/2 littermates.
Collectively, these data suggest that cardiomyocyte-specific expres-
sion of lamin A in Lmna2/2 mice can partially rescue cardiac
function and that the cardiac pathology present in Lmna2/2 mice is
lifespan limiting.
Mosaic expression of lamin A in Lmna2/2 cardiomyocytes was
very likely a limiting factor in many of our incompletely rescued
phenotypes, but also allowed us to observe a juxtaposition of
cardiomyocytes either expressing or not expressing the lamin A
transgene. Other studies had previously used this approach to
address cell autonomy roles in the cardiac system [24,25]. In our
study, Lmna2/2; Tg mice displayed ,30–40% heterogeneity of
lamin A transgene expression in ventricular cardiomyocytes, and
we observed both cell-autonomous and non-cell-autonomous
phenotypes. In general, our findings suggest the contractile defect
of Lmna2/2 mice can be rescued in a cell-autonomous fashion, as
indicated by restoration of the desmin cytoskeletal network in
lamin A-expressing Lmna2/2 cardiomyocytes. We also observed a
significantly decreased fraction of non-transgene expressing
Lmna2/2; Tg cardiomyocytes with disorganized desmin, which
we postulate as being propagated from neighboring cardiomyo-
cytes expressing the lamin A transgene. Since mechanotransduc-
tion relies on communication between the nucleus and extracel-
lular interactions from cell-cell contact, extracellular matrix
composition, and secreted factors [26,27], we propose that A-type
lamins may play an additional role by modulating these
extracellular properties to coordinate mechanosensing and trans-
duction in a non-cell-autonomous manner.
Altered A-type lamin function also results in increased activity
of ERK1/2. Although this phenomenon is universal to many cell
types with abnormal A-type lamin composition [20,28,29,30],
the administration of the MEK inhibitor, PD98059, improves
the dilated cardiomyopathy of LmnaH222P/H222P mice [31,32],
which strongly supports the notion that altered ERK1/2 activity
is a critical component associated with pathogenesis. Indeed,
increased ERK1/2 activity is associated with cardiac hypertro-
phy in other heart disease models [33]. Cx43 is the most widely
distributed member of the connexin family of proteins, which
Figure 3. Lmna2/2; Tg mice display improved contractile function compared to Lmna2/2 littermates. (A) Representative echocardiograms
of Lmna2/2, Lmna2/2; Tg, and control littermates. (B) Normalized left ventricular end-systolic diameter (LVESD) measurements are increased in
Lmna2/2 hearts compared to control hearts and are improved in Lmna2/2; Tg hearts. (C) Normalized left ventricular end-diastolic diameter (LVEDD)
measurements are increased in Lmna2/2 hearts and are not improved in Lmna2/2; Tg hearts. (D) Fractional shortening is decreased in Lmna2/2
hearts compared to control hearts and is improved in Lmna2/2; Tg hearts. (E) Myocardial performance index (MPI) is increased (worse) in Lmna2/2
mice, but is improved in Lmna2/2; Tg mice. For all of the above experiments: Control, N = 13; Lmna2/2, N = 15; Lmna2/2; Tg, N= 12 for 4–8 weeks of
age. One-way ANOVA analyses were performed (B–E) and significant genotype differences are listed above for each panel. Post-tests were performed
between genotypes and significance is listed as follows: * P,0.05; ** P,0.01; *** P,0.001; n.s. not significant.
doi:10.1371/journal.pone.0042918.g003
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forms gap junctions, facilitates cell-to-cell communication, and is
found in a variety of different tissues and cell types [34].
Phosphorylation of Cx43 by ERK1/2 inhibits gap-junctional
communication [21,22], and decreased Cx43 activity at the
intercalated disc in Lmna2/2 mice may play a critical part in the
conduction defects and premature death observed. Electrical
conduction of the heart cannot be completely rescued in a cell-
autonomous fashion as gap junctions must form stable connex-
ons with neighboring cells in order to maintain a functioning
channel, making it an attractive example of non-cell-autonomous
function. Mice carrying a heterozygous deletion for Cx43 [35],
as well as cardiac-restricted inactivation of Cx43 in adult mice
[36,37], show slowing of ventricular conduction and eventual
death by ventricular tachycardia. In addition, heterogeneous or
mosaic expression of Cx43 resulted in similar spontaneous
ventricular arrhythmia and altered conduction velocity [25,38].
We observed heterogeneity in the rescue of gap-junctional Cx43
levels, which we speculate contributes to the continued
premature death phenotype of Lmna2/2; Tg mice through
terminal arrhythmic events. Interestingly, a similar phenotype
describing loss of Cx43 localization to the intercalated disc
coupled with desmin aggregation has been described in D7-des
mice, which encode a deletion that causes human dilated
cardiomyopathy [39]. Additionally, we observed arrhythmia in
two Lmna+/+; Tg mice suggesting that increased expression of
lamin A in a fraction of cardiomyocytes can alter conduction—
and possibly connexin activity—in an otherwise normal heart.
These examples demonstrate the importance of assessing non-
Figure 4. Transgenic expression of lamin A in Lmna2/2 cardiomyocytes partially restores ERK1/2 activation and gap junction
protein localization. (A) Western blot analysis of Lmna+/+, Lmna2/2, and Lmna2/2; Tg mouse heart lysates. Phosphorylated-ERK1/2 (pERK1/2) levels
are increased in Lmna2/2 compared to Lmna+/+ and are decreased in Lmna2/2; Tg hearts while total ERK1/2 levels are unchanged. Total Cx43 protein
levels detected by NT1 are unchanged, while cytoplasmic levels of Cx43 as detected by CT1 are increased. a-tubulin is shown as a loading control. (B)
Quantification of pERK1/2 levels normalized to total ERK1/2 levels in 5–7 week old Lmna+/+ (N = 13), Lmna2/2 (N = 16), and Lmna2/2; Tg (N= 11)
mouse heart lysates. One-way ANOVA analyses were performed for significance with post-test significance values as follows: ** P,0.01; n.s. not
significant. (C–E) Indirect immunofluorescence micrographs of pan-cadherin (red) and Cx43 (green) in Lmna+/+ (C), Lmna2/2 (D), and (E) Lmna2/2; Tg
heart ventricle sections taken at equivalent exposure times from 6-week old mice. Asterisks mark intercalated discs with qualitative decreases in Cx43
relative to pan-cadherin staining. White scale bar denotes 50 mm. (F) Distribution of individual intercalated disks summarizing relative frequency of
Cx43 co-association index in 5–7-week old Lmna+/+ (N = 3; 350 intercalated discs analyzed total), Lmna2/2 (N = 3; 349 intercalated discs analyzed
total), and Lmna2/2; Tg (N= 3; 367 intercalated discs analyzed total) mice. A non-linear regression for Gaussian distribution was fitted for each group
tested (Lmna+/+ R2 = 0.91; Lmna2/2 R2 = 0.96; Lmna2/2; Tg R2 = 0.80). (G) Combined Cx43 co-association indices from multiple experiments
normalized against their respective Lmna+/+ control (N= 3). One-way ANOVA analyses were performed for significance with post-test significance
values as follows: ** P,0.01; n.s. not significant.
doi:10.1371/journal.pone.0042918.g004
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PLOS ONE | www.plosone.org 6 August 2012 | Volume 7 | Issue 8 | e42918
cell-autonomous outcomes in any transgenic and gene therapy
models.
ERK1/2 activity can also result in the activation of different
transcriptional pathways depending on the context of the tissue
type and origin of ERK1/2 activation [40]. A-type lamins can
bind and sequester c-Fos, the immediate downstream effector of
pERK1/2, thereby inhibiting the activity of AP-1 [41]. Further
studies have shown that active ERK1/2 can also co-localize with
lamin A and c-Fos at the nuclear envelope, and the loss of A-type
lamins results in increased AP-1 activity and reduced c-Fos
phosphorylation [29]. Finally, ERK1/2 may additionally act upon
Cx43 in a cell survival pathway, as ERK1/2 activity enhances
translocation of Cx43 to the mitochondria, where Cx43 has been
shown to play a protective role against cell death [42,43,44].
Although it is currently not known whether ERK1/2 signaling can
modulate desmin filament formation in cardiomyocytes, it is
becoming increasingly clear that loss of or mutation of A-type
lamins may impinge on multiple pathways that lead to cardiac
dysfunction.
Our data highlight the role of A-type lamins in cardiomyocyte
function to both maintain efficient contraction and preserve a
functional conductive network. These findings also re-emphasize
the need for uniform expression in gene therapy models correcting
conduction diseases.
Methods
Animals
Lmna+/2 mice were obtained from Dr. Colin Stewart [7] and
were backcrossed on C57BL/6J for 9 additional generations. The
resulting Lmna+/2 mice, B6.129S1(Cg)-Lmnatm1Stw/BkknJ, were
crossed with transgenic mice (founder line 903; B6/CBA F1
hybrids) expressing FLAG-lamin A under the control of the a-
myosin heavy chain promoter, which have been described
elsewhere [16]. The resulting transgenic Lmna+/2 mice were
crossed with Lmna+/2 mice to generate Lmna2/2 mice expressing
the cardiac-specific transgene (Lmna2/2; Tg). Details for genotyp-
ing can be found in Methods S1. Mice were bred and
maintained under specific pathogen-free conditions. All experi-
ments were performed in compliance with the University of
Washington Institutional Animal Care and Use Committee
(Protocol Number: 2174–23).
Figure 5. Lmna2/2; Tg mice show improved conduction parameters compared to Lmna2/2mice by ECG analysis. (A) Box-and-whiskers
plot of pooled Lmna+/+ PR intervals (N = 5) compared with single animal PR intervals for each of the following genetic backgrounds at 5-7 weeks of
age: Lmna+/+; Tg, Lmna2/2 and Lmna2/2; Tg. The whiskers represent at 5–95% confidence interval and individual outliers are represented by their
respective dots. (B) Fraction of mice which display.30% abnormally prolonged PR interval. Lmna+/+ (N = 5), Lmna+/+; Tg (N= 5), Lmna2/2 (N = 6), and
Lmna2/2; Tg (N= 5). (C–E) ECG traces from a Lmna+/+ mouse (C), a Lmna2/2 mouse exhibiting an atrial premature beat (D) and a Lmna2/2 mouse
displaying multifocal atrial rhythm (E). Note the changes in P-wave morphology and cycle length. Arrows denote ectopic P-waves. RR intervals are
shown above.
doi:10.1371/journal.pone.0042918.g005
Figure 6. Extension of median and maximal lifespan in Lmna2/2
mice expressing cardiac lamin A. Lmna2/2; Tg mice display a 12%
and 15% increase in median and maximal lifespans, respectively,
compared to Lmna2/2 littermates (Lmna+/+; Tg N= 10; Lmna2/2 N=24;
Lmna2/2; Tg N=28). The Log-Rank test, which measures significance
evenly across all time points, reports a significance probability of
P,0.0114
doi:10.1371/journal.pone.0042918.g006
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Tissue preparation and indirect immunofluorescence
Hearts of transgenic and non-transgenic Lmna2/2 and control
mice were rapidly excised and rinsed in phosphate-buffered saline
(PBS) prior to mounting in Tissue-Tek O.C.T. compound and
subsequent freezing in liquid nitrogen-cooled isopentane. Heart
ventricle sections 8 mm in thickness were collected and mounted
on Superfrost plus glass slides (Fisher). Antibodies used and
detailed methods for staining and scoring desmin and connexin
can be found in Methods S1.
Western analysis
Tissues were homogenized using the TH homogenizer (Omni
International) in a lysis buffer (10 mL/mg tissue) containing the
following: 2% SDS, 250 mM sucrose, 75 mM urea, 1 mM DTT,
50 mM Tris (pH 7.5), 25 mg/mL aprotinin, and 10 mg/mL
leupeptin [13,19]. Antibodies used and further details can be
found in Methods S1.
Echocardiography
Transgenic and non-transgenic Lmna2/2 mice and control
littermates received echocardiography examination (Siemens
Acuson CV70). A mixture of 0.5% isoflurane with O2 was
administered through a nose cone to provide adequate sedation
but minimal cardiac suppression during echocardiography. Heart
rate was monitored and kept above 400 bpm to minimize any
effect on any parameters [45]. Pathologists performing the
echocardiography examination were blinded to the transgene
genotype for Lmna2/2 mice. Further details can be found in
Methods S1.
ECG recordings
Electrocardiography was recorded using TA11ETA-F10 transmit-
ters (Data Science International, St.Paul, MN). ECG data were
recorded using Dataquest A.R.TTMsoftware (Data Sciences Interna-
tional) and the first 300 beats were analyzed using LabChart7 Pro
(ADInstruments). Further details can be found in Methods S1.
Statistical analysis
Data are expressed as mean 6 S.E.M. and one-way ANOVA
analyses were performed where relevant with Bonferroni post tests
to compare genotypes of specific age groups. A value of P,0.05
was considered statistically significant. For lifespan analysis, a
Kaplan-Meier curve was generated and Log Rank Tests were
performed with a value of P,0.05 that was considered statistically
significant. All statistical analyses and graphs were performed
using GraphPad Prism 5.02.
Supporting Information
Figure S1 Lmna+/+ and Lmna+/+; Tg hearts show no
significant difference in cardiac function. (A & B) No
significant difference is noted in (A) fractional shortening, (B)
myocardial performance index (MPI), or (C) left ventricular mass
index (LVMI) of Lmna+/+ and Lmna+/+; Tg hearts at 4–8 weeks of
age as measured by echocardiography. Two-tailed unpaired t-tests
were used to determine P-values which are listed for each panel.
(Lmna+/+, N= 6; Lmna+/+; Tg, N=7).
(TIF)
Figure S2 Lmna2/2 hearts are enlarged relative to
control littermates and Lmna2/2; Tg hearts are not
significantly improved. Left ventricular mass of 4–8 week old
mice was measured and normalized to body weight to resolve the
LVMI. One-way ANOVA was performed and significant genotype
differences are listed for each panel. Bonferonni post-tests were
performed between genotypes and significance is listed as follows: *
P,0.05; n.s. not significant. (Control, N=13; Lmna2/2, N=15;
Lmna2/2; Tg, N=12).
(TIF)
Figure S3 mRNA levels of global remodeling markers,
ANF and BNP, are enriched in Lmna2/2 and Lmna2/2;
Tg mice. qPCR of cardiac remodeling mRNA’s for Lmna2/2 and
Lmna2/2; Tg hearts. Data are presented as fold-increase over
Lmna+/+ hearts. Global cardiac remodeling mRNA’s, ANF and
BNP, are all increased in Lmna2/2 hearts and are not significantly
changed in Lmna2/2; Tg hearts. (Lmna+/+, N= 4; Lmna2/2, N= 7;
Lmna2/2; Tg, N=5).
(TIF)
Figure S4 Dropped beat in Lmna+/+; Tg heart. An
isolated case of a dropped heartbeat was noted in a single
Lmna+/+; Tg heart during ECG recording which could reflect
either a sinus pause or sino-atrial block.
(TIF)
Table S1 Average ECG parameters from 5–7 week old
mice. ECG parameters of individual mice from Lmna+/+ and
Lmna2/2 mice either expressing or not expressing FLAG-lamin A
in cardiomyocytes. Similar mouse genotypes are grouped together
with mouse ID displayed and parameters are averaged. Each
parameter from an individual mouse represents an averaged value
from the first 300 beats recorded. Parameters include RR interval,
Heart Rate, PR interval, P duration, and QRS interval.
(TIF)
Methods S1 Additional information and specifics on
methods with supporting references. Further details include
genotyping primers, qPCR primers, specific antibodies used for
both immunofluorescence and Western blotting, details on image
analysis, and animal techniques.
(DOC)
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